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Abstract 
Purpose Recent attempts to include adverse effects of pathogens on human health in life cycle assessment (LCA) 
have focused on integrating results obtained through quantitative microbial risk assessment (QMRA) as an 
impact category in LCA. This study aims to investigate whether the use of QMRA can be an adequate way of 
integrating pathogen impact potential in LCA, and to quantify how pathogen impact potential is affected by 
choices regarding model structure and mathematical relationships used. 
Method This study is performed for the context of sewage sludge management and is based on pathogen 
concentrations in treated sludge reported in the literature. Eight reference pathogens were included in order to 
address important microbial groups. The pathogen impact potential associated with land application of sewage 
sludge was quantified based on a QMRA model for eight distinct exposure pathways. The modelling choices 
investigated were linearisation of dose-response and severity assessment, and different modelling approaches 
and parameter choices in fate and exposure assessment. 
Results and discussion The linearisation of effect and severity assessment had a minor impact on the results for 
exposure pathways where pathogen doses were low, but had a major impact where pathogen doses were high. 
The assumptions regarding fate and exposure conditions, such as pathogen decay time, number of individuals 
exposed, and frequency of exposure, had a significant effect on overall pathogen impact potential. If pathogen 
impact potential is to be integrated in LCA, a range of different parameterisations for each exposure event may 
be warranted rather than only the one with the highest risk per individual exposed as commonly reported for 
QMRAs. This is also in line with the ordinary LCA practice of focusing on average rather than extreme 
conditions. 
Conclusions and recommendations This study suggests that the use of QMRA can be an adequate way of 
integrating adverse effects of pathogens on human health in LCA. However, analysts should be careful when 
choosing model parameters such as the number of people exposed or the frequency of exposure, as LCA may 
require a different parameterisation than an ordinary risk assessment (RA). Therefore, a direct integration of the 
results of a QMRA study into LCA may be problematic. Also, in order to avoid potential bias, analysts should 
carefully consider whether or not pathogen impact potential and human toxicity potential need to be estimated 
based on a similar set of exposure pathways. 
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1 Introduction 
In the context of wastewater and sewage sludge management, human health risks associated with hazardous 
chemicals and microorganisms present in wastewater and sewage sludge are of particular concern. The health 
risks related to particular wastewater and sewage sludge management options are commonly quantified in risk 
assessment studies (e.g. Brooks et al. 2012; Gale 2005; Schoen et al. 2014). Toxic effects of chemicals on human 
health (human toxicity) have also been assessed in lifecycle assessment (LCA) studies (for recent reviews of 
LCA studies in the context of wastewater and sewage sludge management the reader is referred to Corominas et 
al. 2013 and Yoshida et al. 2013), with a focus on wider impacted regions compared to local impacts addressed 
by risk assessment (RA) studies. Life cycle impact assessment (LCIA) models to assess human toxicity are 
under continuous development (Hauschild et al. 2013). However, there are currently no standard LCIA models 
available for the inclusion of adverse effects of pathogens on human health (pathogen impact potential) in LCA. 
As a result, pathogen impact potential is rarely included in LCA studies. 
In recent years, a number of attempts have been made to integrate quantitative microbial risk assessment 
(QMRA) results into an LCA framework (Aramaki et al. 2006; Harder et al. 2014; Heimersson et al. 2014; 
Kobayashi et al. 2015; Larsen et al. 2009). These studies essentially estimated the burden of disease associated 
with the exposure of humans to pathogens as a result of wastewater and sludge management operations for a 
varying number of pathogens and exposure pathways based on QMRA. Hereby, the burden of disease was 
expressed in terms of disability-adjusted life years (DALYs), a concept developed for the World Health 
Organisation (Murray 1994). This pathogen-related burden of disease was then presented in an LCA framework 
and treated as an LCA impact category. Clearly, pathogen impact potential and human toxicity potential both 
represent potential impacts on human health, and can be expressed in terms of DALYs (Gao et al. 2015). But is 
the integration of QMRA results in an LCA framework an adequate way of addressing the adverse effects of 
pathogens on human health in LCA? 
Traditionally, LCIA does not take into account the time-space distribution of stressors and effects. 
Currently available LCIA models for human toxicity of chemicals (e.g. the USEtox™ model) for instance 
usually are steady-state fugacity-based compartment models. The compartments included in fate assessment 
often represent compartments at larger spatial scales (e.g. the regional or global scale), although efforts are made 
to increase the level of spatial resolution and differentiation. Exposure assessment may not include occupational 
exposure and usually does not address different sub-populations (Rosenbaum et al. 2011). Effect assessment is 
usually based on linear mathematical relationships. But more importantly, parameter values in fate and exposure 
assessment usually represent routine operations under realistic average conditions. This approach is in line with 
common practice in LCA, namely to base the comparison of the performance of different product or service 
systems, or different life cycle phases of a product or service system, on a typical situation when technical 
systems operate according to the design specifications. 
When it comes to adverse effects of pathogens on human health, however, the operation conditions with 
significant impacts may be events where processes do not work as they are supposed to. These are the conditions 
commonly addressed in QMRA. Because of a significant variability in the procedures and locations used for 
wastewater and sewage sludge management, the assessment of pathogen risk using QMRA is usually 
characterised by a high level of spatial and temporal specificity regarding transport, fate, and exposure 
conditions (Haas et al. 2014). Exposure assessment often includes occupational, recreational, as well as 
residential activities. Moreover, many of the mathematical relationships used in effect assessment are non-linear. 
In QMRA, parameter values in fate and exposure assessment often represent realistic worst-case conditions, 
aiming at identifying critical exposure pathways, exposure conditions, and sub-populations (Haas et al. 2014). In 
the context of wastewater and sewage sludge management, the frequency of the occurrence of operating 
conditions where the system does not work according to the design specifications may warrant consideration of 
adverse effects of pathogens on human health also in LCA. In LCA, however, the focus is on the overall impact 
for a given human population rather than on risks for specific members of a given human population. When it 
comes to addressing adverse effects of pathogens on human health in LCA, two questions thus are of interest and 
are addressed by the present study.  
The first question is whether the mathematical relationships and the model structure of QMRA can be 
simplified and made more generic, similar to the development of generic LCIA models for human toxicity of 
chemicals starting from mathematical relationships established within chemical RA. To this end, the aim of the 
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present study was to identify and explore possible modifications to the mathematical relationships and model 
structure applied in QMRA. The modifications identified and investigated in this study were inspired by the 
model structure and mathematical relationships underlying the USEtox™ model (Henderson et al. 2011; 
Rosenbaum et al. 2011). It should be noted that other LCIA methods for the characterisation of human toxicity, 
such as ReCiPe (Goedkoop et al. 2009), could have served as a starting point, but were not considered different 
enough in structure to warrant further study. 
The second question is how pathogen impact potential is affected by different modelling choices pertaining 
to the mathematical relationships and model structure applied. In the present study, this comparison was made 
for eight exposure pathways related to land application of sewage sludge. The context of land application of 
sewage sludge was chosen because it is considered one option for recycling nutrients to productive land, 
alongside a range of more technical alternatives that involve extraction of nutrients from sludge or from solids 
remaining after partial or complete sludge oxidation (e.g. supercritical water oxidation, incineration). Land 
application of sewage sludge has been debated in Sweden (Bengtsson and Tillman 2004) and elsewhere for 
many years due to concerns about inorganic pollutants (e.g. heavy metals), organic pollutants (e.g. industrial 
chemicals, pharmaceutical residues, and hormones), and pathogens (e.g. bacteria, viruses, and parasites) present 
in the sludge.  
Based on the findings from the case study on sewage sludge management, the present study provides 
recommendations on how to include pathogen risk in LCA, also in contexts other than sewage sludge 
management. 
2  Methods 
2.1 Baseline model 
The baseline model follows a classical QMRA approach where each exposure pathway is modelled individually 
and effect assessment is based on non-linear dose-response relationships.  Which model is used depends on the 
pathogen under consideration (Online Resource 1). Dose-response relationships for pathogens describe the 
relationship between a given pathogen dose per exposure event (De) and the corresponding probability of 
infection (or illness) per exposure event (Pe). In QMRA, dose-response relationships for pathogens usually are 
represented by non-linear mathematical relationships, such as the exponential model or a beta-Poisson model 
(Online Resource 1). The exposure pathways relevant for land application of sewage sludge as well as the 
mathematical relationships in the baseline model were largely based on Brooks et al. (2012) and Gale (2005) 
(further details are provided in Online Resource 1). The number of individuals exposed (nind) and the frequency 
of exposure (fexp) were largely based on Westrell et al. (2004), who investigated a wastewater treatment system 
treating 12 500 m3 wastewater per day on average (serving 28 600 people), and consisting of primary and 
secondary treatment (activated sludge process with biological nitrification-denitrification and chemical 
phosphorus removal), tertiary treatment (constructed wetland), anaerobic sludge digestion, and land application 
of digested sewage sludge (further details are provided in Online Resource 1). The reference pathogens included 
in the current study were Campylobacter jejuni, Salmonella enterica (non-typhi), Listeria monocytogenes, 
pathogenic Escherichia coli (strain O157:H7), human infectious Adenovirus, human infectious Enterovirus 
(represented by Coxsackie B virus), Giardia lamblia, and Cryptosporidium spp. The receptors covered are adults 
and children (exposed to pathogens through accidental, intentional, or routine ingestion or dermal contact during 
occupational, recreational, or residential activities) (see Table 1 and Figure 1). 
2.2 Modifications regarding mathematical relationships used in effect and severity assessment 
Linearisation of dose-response relationships (modification 1) 
In the USEtox™ model, the dose-response relationships for chemicals are represented by a linear mathematical 
relationship. The human-toxicological effect factor for chemicals is calculated under the assumption of linearity 
in dose-response between zero and the point ED50 at which the lifetime disease probability is 0.5 (Huijbregts et 
al. 2010). In mathematical terms, the analogous modification to the baseline model would be the replacement of 
the exponential or beta-Poisson dose-response model with a linear one (Equation 1), where ID50 represents the 
dose where the probability of infection (or illness) is 0.5.  
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(1)  
The linearisation shown in Equation 1 is expected to cause an underestimation of the probability of 
infection (or illness) for low pathogen doses (De < ID50) and an overestimation for high pathogen doses (De > 
ID50). For a graphical representation of the original (i.e. exponential or beta-Poisson) and the modified (i.e. 
linearised) dose-response models see Figure 2 and Online Resource 1.  
It is important to realise that the probability of infection (or illness) per exposure event (Pe) can exceed 1 in 
Equation 1. Also the mathematical formulation of the linearised concentration-response model reported in the 
USEtox™ user manual (Huijbregts et al. 2010) is unbounded and it would appear that it extends linearly also for 
probabilities above 0.5 even though the assumption of linearity is applied only for disease probabilities below 
0.5. In the case of human toxicity of chemicals, this is not an issue in practice, as the assessment concerns 
lifetime disease probabilities resulting from chronic exposure. The emissions of chemicals considered in a given 
LCA study only constitute marginal contributions well below a lifetime disease probability of 0.5. In the case of 
pathogen impact potential, however, the probability of infection (or illness) is related to acute effects, and the 
emission of pathogens considered in a given LCA study can easily reach above a disease probability of 0.5. 
When investigating pathogen impact potential, it is therefore useful to see linearisation of dose-response 
relationships as consisting of two components: the actual linearisation on the one hand, and the removal of the 
upper boundary (i.e. Pmax = 1) on the other hand. In order to be able to judge the effect of these two components 
individually, a piece-wise linearisation (Equation 2) was considered as an alternative to the full linearisation 
(Equation 1). 
 (2)  
The piece-wise linearisation of the dose-response relationship (Equation 2) will henceforward be referred to 
as modification 1a and it aimed at investigating the effect of changing the shape of the dose-response curve 
whilst retaining an upper boundary (i.e. Pe,max = 1) for the probability of infection or illness (Pe). The removal of 
the upper limit for the probability of infection or illness, leading to a full linearisation of the dose-response 
relationship (Equation 1), will henceforward be referred to as modification 1b. 
Linearisation of severity assessment relationships (modification 2) 
In order to convert the probability of infection or illness (Pe) per exposure event into a burden of disease, the first 
step is to calculate the annual probability of infection or illness (Pa), taking into account the number of exposure 
events of a certain type an individual is exposed to during a year (ne). In mathematical terms, linearisation of 
severity assessment relationships corresponds to replacing Equation 3 used in the baseline model with Equation 
4. 
 (3)  
 (4)  
On a conceptual level, this modification implies that the annual probability of infection or illness (Pa) no 
longer represents the probability of one individual becoming subject to infection or illness once or more in a year 
(i.e. Equation 3 counts an individual infected several times a year as one case of infection), but the actual number 
of infections, neglecting immunity effects and the duration of an infection (i.e. Equation 4 counts an individual 
infected on two successive months as two cases of infection). For small probabilities of infection or illness per 
exposure event (Pe), the annual probabilities of infection or illness (Pa) calculated using Equation 3 and Equation 
4, and hence the annual number of cases of infection or illness (Na), are nearly identical. For larger probabilities 













Pa = 1  (1  Pe)ne
Pa = Pe · ne
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Investigating the effects of linearization in effect and severity assessment 
In order to investigate the effect of linearisation on estimated pathogen risk, five model variants were conceived. 
Model variant BL represents the baseline model (i.e. classical QMRA approach with effect assessment based on 
non-linear mathematical relationships) whereas model variants M1-M4 represent distinct combinations of the 
first two model modifications (Table 2). 
2.3 Modifications regarding the overall model structure of fate and exposure assessment 
Exclusion of certain exposure pathways from the analysis (modification 3) 
Not all exposure pathways covered by the baseline model for pathogens are covered in the USEtox™ model for 
chemicals. For instance, occupational exposure and accidental exposure by children to sewage sludge at 
wastewater treatment facilities and on agricultural fields are not considered in the USEtox™ model. Rather, the 
USEtoxTM model only considers exposure pathways originating in compartments at the continental and global 
scales. Further, all humans in the respective region are assumed to be exposed to the steady-state concentrations 
by breathing air, drinking water, and ingesting food products. No distinction is made between sub-populations. 
Given the set of exposure pathways considered in this study in the context of land application of sewage sludge, 
Modification 3 consists of limiting the set of exposure pathways to the consumption of produce grown on 
sludge-amended land (exposure pathway E8 in Table 1). This exposure pathway is the only one considered in 
this study that is included in the USEtoxTM model. In order to investigate the effect of modification 3, the model 
results for each model variant were reported separately for exposure pathway E8 in addition to the aggregated 
results for exposure pathways E1-E8 and E1-E7, respectively (Table 3). 
Different modelling approaches and parameter choices regarding exposure pathway E8 
For exposure pathway E8, the effect of different modelling approaches and parameter choices was investigated. 
Particular attention was given to the assumptions regarding exposure parameters (i.e. amount of produce 
consumed per individual exposed, frequency of exposure, number of individuals exposed). Four scenarios were 
investigated (Table 4).  
The parameterisation in scenarios S1 and S2 was based on Brooks et al. (2012) regarding the amount of 
vegetables (grown on sewage sludge-amended land) eaten per individual (ring) and based on Westrell et al. 
(2004) regarding the number of individuals exposed (nind) and the frequency of exposure through consumption 
(fexp). In scenario S1, the decay time in soil (ts) and on crops (tc) were chosen to represent an ideal situation with 
nominal system performance (i.e. the system works as it is supposed to, the time lag between sludge spreading 
and harvesting is ts=90d and the time lag between harvesting and consumption is tc=10d). In scenario S2, the 
decay time on soil and crops were chosen to represent a bypass situation (i.e. the time lag between sludge 
spreading and harvesting is ts=5d and the time lag between harvesting and consumption is tc=0d).  
The parameterisation in scenario S3 is based on Gale (2005) (ring, nind, fexp). Gale (2005) assumed that 1 150 
000 people in the UK consume vegetables crops (all year) grown on land treated with sewage sludge; this 
estimate was based on the application of 520 000 tonnes of dry sewage sludge to agricultural land. In the current 
study, sewage sludge production is estimated to be 2 150 tonnes of dry sludge, based on the assumption of a 
sludge production of 75 kg per capita per year and 28 600 people connected to the treatment plant. Based on the 
study of Gale (2005), hence assuming conditions similar to the UK, the number of people exposed in the present 
study would be 4 750. The decay time in soil and on the crops were chosen to represent an ideal situation with 
nominal system performance. For scenarios S1-S3, the overall burden of disease could be calculated for each 
model variant (BL and M1-M4). 
Scenario S4 represents a different approach and did not require the specification of the amount of 
vegetables (grown on sewage sludge-amended land) eaten per individual (ring), the frequency of exposure 
through consumption (fexp), nor the number of individuals exposed (nind). Rather, this approach of calculating the 
burden of disease (BoD) associated with land application of sewage sludge started from the amount of pathogens 
emitted (pem), which is a function of the pathogen concentration in the sewage sludge (c) and the application rate 
(AR). A fraction of these pathogens was assumed to remain infectious in the soil after decay processes (fs), a 
sub-fraction of these transferred to the crop (fsc), and yet another sub-fraction remained on the crop after further 
decay processes (fc). Essentially, this approach was based on linear mathematical relationships and attempted to 
calculate an intake fraction (iF), which can then be multiplied with an effect factor (EF) based on ID50 and the 
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burden of disease per case of infection (BoDcase). The model variant applied to scenario S4 is referred to as 
model variant ALT and is represented in Equation 5.  
(5)   
2.3 Model implementation 
All model variants and modelled scenarios started from the pathogen concentrations in treated (digested and 
dewatered) sewage sludge reported in the literature (Bofill-Mas et al. 2006; Gale 2005) (Online Resource 1). The 
pathogen concentrations and parameter values are provided in Online Resource 1. All model variants were built 
in both MATLAB R2014a and Microsoft Excel 2011 for validation purposes. 
3 Results 
3.1 The effect of linearisation of effect and severity assessment relationships 
Aggregated effects at the level of the overall burden of disease 
For each model variant, the burden of disease was calculated and aggregated over all exposure pathways and 
reference pathogens (Table 3). Modification 1a (i.e. linearisation of dose-response relationships while retaining 
the upper boundary of the probability of infection or illness) seemed to have little effect overall (M1 versus BL). 
Modification 2 (i.e. linearisation of severity assessment relationships) increased the overall pathogen impact 
potential in model variants M2 and M3 by a factor of 7 compared to the baseline model variant BL. Modification 
1b (i.e. full linearisation of dose-response relationships) had the most pronounced effect, as the pathogen impact 
potential in model variant M4 was increased another factor of 84 compared to model variant M3. Note that these 
findings did not apply to all individual combinations of pathogen and exposure pathway but relate to the overall 
results. 
Effects at the level of distinct combinations of pathogen and exposure pathway 
For some distinct combinations of pathogen and exposure pathway, the different model variants provided similar 
results (see pathogens P2 and P7 in Figure 3). For other combinations of pathogen and exposure pathway, 
however, deviations between model variants were significant (see pathogen P1 in Figure 3). The detailed results 
obtained for the different model variants are provided in Online Resource 1 for every combination of pathogen 
and exposure pathway. 
For exposure frequencies (fexp) considerably above 1, linearisation of severity assessment (modification 2) 
led to a higher burden of disease estimate in model variant M2 in comparison to the baseline model variant BL, 
and in model variants M3 and M4 in comparison to model variant M1. In other words, modelling one individual 
exposed ten times per year as ten individuals exposed once per year will yield a higher burden of disease 
estimate. This effect was more pronounced at higher exposure frequencies (fexp) and at higher pathogen doses 
(De). For pathogen doses below (respectively above) ID50, as expected, piece-wise linearisation of the dose-
response relationship (i.e. linearisation with retaining the upper boundary of the probability of infection or 
illness) (modification 1a) led to a lower (respectively higher) burden of disease estimate in model variant M1 in 
comparison to the baseline model variant BL, and in model variants M3 and M4 in comparison to model variant 
M2. Although linearisation of severity assessment (modification 2) and piece-wise linearisation of dose-response 
assessment (modification 1a) did have an effect on pathogen risk, this effect was relatively small. 
The effect of the removal of the upper boundary of the probability of infection or illness as a result of full 
linearisation of dose-response assessment (modification 1b), however, was potentially significant. For 
combinations of pathogen and exposure pathway subject to high pathogen doses per individual exposed, the 
removal of the upper boundary for the probability of infection or illness (modification 1b) led to a considerably 
higher burden of disease estimate in model variant M4 in comparison to model variant M3 (particularly for 
exposure pathway E2). 
BoD = c · AR| {z }
pem
· 10 ds·ts| {z }
fs
· ks,c · kc,c| {z }
fsc





· BoDcase| {z }
EF| {z }
CF
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3.2 The effect of adaptations to the overall model structure and variation in fate and exposure 
assessment 
For each model variant, the burden of disease was calculated for exposure pathways E1-E7, E1-E8, and E8 
separately (Table 3). The initial model parameterisation of exposure pathway E8 (scenario S1) essentially 
assumed that 500 individuals eat 292 grams of contaminated vegetables twice a year, and that vegetables are 
harvested 90 days after sludge application and eaten 10 days after harvest. For this model parameterisation, the 
contribution of exposure E8 was negligible. As there is more produce available from sludge-amended fields than 
consumed in this scenario, the analysis follows the implicit assumption that all remaining produce is free of 
pathogens. If exposure pathway E8 is parameterised differently (Table 4), its contribution to the overall burden 
of disease becomes more significant, particularly for scenario S2 (bypass situation) and scenario S4 (alternative 
modelling approach using model variant ALT). Yet, it is difficult to draw general conclusions about the 
significance of exposure pathway E8 as also other exposure pathways may be modelled and parameterised 
differently. 
4 Discussion 
4.1 Sources of uncertainty 
This study explored several modifications to the mathematical relationships and model structure underlying 
QMRA with intent to make the characterisation of pathogen impact potential more akin to traditional LCIA 
models for the characterisation of human toxicity potential. It is important to recall that this study is based on 
pathogen concentrations and a set of exposure pathways described in the literature rather than the actual 
pathogen concentrations and exposure pathways characteristic of a specific site. Therefore, different results may 
have been obtained if different sludge qualities or a different set of exposure pathways had been considered. 
Nevertheless, the main findings of this study regarding the effect of linearisation in effect assessment can be said 
to be robust towards these sources of uncertainty. Regarding fate and exposure assessment, this study indicated 
that the choice of exposure pathways, modelling approach and model parameterisation represent major sources 
of uncertainty. Different assumptions regarding model parameters (i.e. pathogen decay time, number of 
individuals exposed, frequency of exposure) strongly influenced the estimated pathogen risk. Although only one 
exposure pathway was investigated in detail regarding the effect of modelling approach and parameterisation, 
this finding is deemed to be valid also for other exposure pathways and contexts. Finally, a potentially relevant 
aspect that was not addressed in the present study is the use of dynamic model concepts that address immunity 
and secondary spread (Eisenberg et al. 2002; Eisenberg et al. 2004; Eisenberg et al. 2008; Soller 2009). Neither 
was specific attention given to the uncertainties related to the estimation of pathogen concentration in sewage 
sludge through different sampling procedures.  
4.2 Towards good practice for the integration of pathogen risk in LCA 
Linearisation of mathematical relationships not always possible 
When addressing pathogen risks related to exposure pathways with relatively low pathogen doses per exposure 
event, linearisation of dose-response relationships appears possible. For example, for the consumption of 
produce grown on sludge-amended land, the calculation model for pathogen risk could be conceived in a manner 
similar to models for human toxicity of chemicals (e.g. the USEtoxTM model). The use of linear mathematical 
relationships in effect assessment would enable the combination of an effect factor (EF) based on a linear dose-
response relationship with a pathogen intake fraction (iF). Thus, for the consumption of produce grown on 
sludge-amended land, it would be possible to calculate a characterisation factor (CF) representing a certain 
sewage sludge application regime (i.e. a given application rate, decay rates and time lags between land 
application and harvest) (Equation 5). When addressing pathogen risks related to occupational exposures and 
other exposures with potentially higher pathogen doses per exposure event, however, full linearisation of dose-
response relationships (modification 1b) appears inappropriate because it could lead to an overestimation of the 
pathogen impact potential by several orders of magnitude. 
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Implications for scaling to a functional unit 
In LCA, scaling to a functional unit usually takes place before fate, exposure and effect assessment. In 
combination with LCIA models for human toxicity of chemicals, this is acceptable, as all mathematical 
relationships are linear and the emissions of chemicals considered in a given LCA study usually are marginal 
contributions to a lifetime disease probability. The situation is different for pathogens, where the effects 
considered are acute rather than chronic. In those cases where full linearisation of dose-response relationships is 
inappropriate for the estimation of pathogen impact potential, the nonlinearity implies that pathogen doses need 
to be expressed in absolute terms rather than as marginal increase. This in turn implies that pathogen emissions 
cannot be scaled to a functional unit before fate, exposure and effect assessment, as otherwise nonlinearities in 
the dose-response relationship would not be properly accounted for. Still, scaling to a functional unit is possible, 
it just needs to be done after effect assessment (Harder et al. 2015). 
Overall model structure and parameterisation 
Broadly speaking, the assessment of adverse effects related to pathogens requires the identification of a set of 
exposure pathways to be considered in the analysis. For each exposure pathway, over the course of time there 
occur a number of exposure events, during each of which the receptor is exposed to a certain pathogen dose (De). 
Furthermore, a certain number of individuals are affected, and specific individuals may get exposed once or 
more. This simply means that, for each exposure pathway considered in a given study, the corresponding 
exposure events can in principle be parameterised in different ways, reflecting different exposure conditions. For 
example, one parameterisation may represent nominal system performance while another parameterisation may 
represent periods of poorer system performance for the same exposure pathway. The usual rationale followed in 
a QMRA framework is to limit the analysis to one specific parameterisation of exposure event per exposure 
pathway. The parameters are chosen such as to reflect realistic worst-case circumstances in terms of the highest 
burden of disease per individual exposed. For this critical exposure event, the analyst defines the pathogen dose 
(De), the number of individuals exposed (nind), and the number of exposure events these individuals are exposed 
to during a year (fexp). Considering only one critical parameterisation of exposure event is perfectly acceptable 
and appropriate in a QMRA framework, yet there is a general move towards more stochastic assessments that 
cover a suite of reference pathogens (Sales-Ortells and Medema, 2015).  
In an LCA framework, however, considering only the parameterisation of exposure event with the highest 
burden of disease per individual exposed may not be appropriate. Say one worker gets exposed to a given 
pathogen dose, corresponding to a probability of infection of 0.7, once per year (event A1). Say another twenty 
workers each get exposed to a third of this pathogen dose, corresponding to a probability of infection of 0.3, 
once per year (event A2) through the same exposure pathway (exposure pathway A). In a QMRA framework, 
where the focus is on risks for specific members of a given human population, exposure event A1 clearly is the 
critical one. In an LCA framework, however, where the focus is on overall impact, exposure event A2 may be 
the critical one, as the larger number of people exposed may lead to a higher overall burden of disease despite 
the less critical parameterisation of this exposure event (from the perspective of one individual exposed).  
Because LCA focuses on overall impacts (i.e. the overall burden of disease for pathogen impact potential), 
it would in principle be necessary to consider a broader set of parameterisations for each individual exposure 
event. This set of parameterisations may then reflect a variety of exposure conditions during both nominal 
system performance and periods of poorer system performance or system mismanagement (bypass situations). 
The different exposure conditions could then be weighted before including the results in an LCA framework. 
Comparability of pathogen impact potential and human toxicity potential in an LCA framework 
The QMRA model for pathogen risk investigated in this study covered more exposure pathways than the 
USEtoxTM model for the assessment of chemical risk. Even if parameterised in accordance with the principles 
applied in an LCA framework, the pathogen risk estimated using such a QMRA model may therefore not be 
directly comparable with chemical risk estimated based on the USEtoxTM model. Including a broader set of 
exposure pathways for pathogens than for chemicals may introduce bias if chemical risk and pathogen risk are 
compared to each other. Such bias would essentially result from the inclusion of certain exposure pathways for 
pathogen risk whilst the same exposure pathways are neglected for chemical risk. Hence, also the aggregation of 
the respective burden of disease estimates for pathogen risk and chemical risk may be problematic. It therefore 
appears worthwhile to investigate the influence of modelling choices also for chemical risk through a 
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comparison of the chemical risks estimated using LCIA models such as the USEtoxTM model with chemical risks 
estimated using a model structure more similar to QMRA. Such fate and transport models would be based on 
site-specific exposure pathways rather than multimedia fate and transport models covering larger spatial scales. 
Hence, using site-specific data would provide a second perspective on the question whether the integration of 
pathogen impact potential (assessed using mathematical relationships based on QMRA) in an LCA framework 
alongside human toxicity potential (assessed using fugacity-based LCIA models) introduces bias. 
5 Conclusions and recommendations 
When combining QMRA and LCA, analysts should be aware of the differences between the QMRA and LCA 
frameworks. Based on this study and previous expertise of the authors, we argue that the direct integration of the 
results of a QMRA study into an LCA framework can be problematic. However, the use of QMRA as a 
substitute for non-existent LCIA models for the estimation of pathogen risk can be an adequate way of 
integrating pathogen risk in an LCA framework alongside LCIA models for the assessment of other potential 
impacts on human health, but generally only if the model is parameterised in accordance with the principles 
applied in the LCA framework. Hereby, analysts should be particularly careful when making assumptions 
regarding exposure conditions such as pathogen decay, the number of people exposed, and the frequency of 
exposure. These assumptions strongly influence the estimated pathogen risk. Finally, analysts should carefully 
consider whether the quantification of chemical risks and pathogen risks needs to be based on a similar set of 
exposure pathways, or rather on pathways of highest risk for each hazard class - with specific identification of 
such. 
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Fig. 1 Overview of fate, transport, and exposure pathways 
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Fig. 2 Dose-response models for non-typhi salmonella (P3). See Online Resource 1 for the respective dose-
response models of the remaining reference pathogens considered in this study 
 
 
Fig. 3 Calculation results for the different modelling approaches per pathogen for exposure pathway E2 
(ingestion of treated sewage sludge by worker during sludge spreading). Red dots (left of the dotted lines) 
represent the baseline model variant BL (denoted as B in the figure). Black dots (right of the dotted lines) 
represent model variants M1-M4 (denoted as 1-4 in the figure), respectively. The respective graphs for all 
combinations of pathogens and exposure pathways are provided in Online Resource 1. Model variants: BL 
(baseline, no modifications), M1 (modification 1a), M2 (modification 2), M3 (modifications 1a and 2), M4 
(modifications 1a, 1b and 2) 
 
Tables 
Table 1 Overview of exposure pathways including exposure frequency and individuals exposed 
ID Activity type Specific activity Exposure  Receptor 
E1 occupational sludge spreading fomite  fomite contact adult 
E2 occupational sludge spreading treated sludge ingestion adult 
E3 occupational working on agricultural field soil ingestion adult 
E4 recreational playing at sludge storage treated sludge ingestion child 
E5 recreational playing on field treated sludge ingestion child 
E6 recreational playing on field soil ingestion child 
E7 residential living close to field soil ingestion adult 
E8 residential alimentation crops ingestion adult 
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Table 2 Overview of the different combinations of model modifications applied in different model variants 
Variant Modification 1a Modification 1b Modification 2 
BL    
M1 Y   
M2   Y 
M3 Y  Y 
M4 Y Y Y 
 
Table 3 Pathogen risk estimated using the different model variants 
Variant E1-E8 
Burden of disease 
(mean) 
E1-E7 
Burden of disease 
(mean) 
E8 
Burden of disease 
(mean) 
BL 1.3  1.3  1.3x10-6  
M1 0.8 0.8 1.0x10-6   
M2 8.8 8.8 1.3x10-6   
M3 9.3 9.3 1.0x10-6  
M4 783 783 1.0x10-6  
 
Table 4 Different calculation approaches and parameter choices for exposure pathway E8. Details regarding the 
assumptions underlying the choice of parameter values are provided in Online Resource 1. Model results 
represent an overall burden of disease in DALY 
Scenario ts tc ring fexp nind BL M1 M2 M3 M4 ALT 
S1 90 10 292 2 500 1.3x10-6 1.0x10-6  1.3x10-6 1.0x10-6 1.0x10-6 n.a. 
S2 5 0 292 2 500 1.1x100 0.8x100   1.3x100   1.0x100   1.0x100   n.a. 
S3 90 10 30 365 5000 2.5x10-4 1.8x10-4  2.5x10-4  1.8x10-4  1.8x10-4  n.a. 
S4 90 10 n.a. n.a. n.a. n.a. n.a. n.a.  n.a.  n.a.  1.9x10-1 
ts: decay time in soil [d], tc: decay time on crop [d], ring: rate of ingestion [g d-1], fexp: frequency of exposure [yr-1], 
nind: number of individuals exposed [cap] 
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